Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine
Xiaoyi Zhang, 1, 2 Yixin Zhang, 1, 2 Yaonan Wang, 1, 2 Jianhui Wu, 1, 2 Haiyan Chen, 1, 2 Ming Zhao, 1–3 Shiqi Peng 1, 2 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Capital Medical University, B...
Guardado en:
Autores principales: | Zhang X, Zhang Y, Wang Y, Wu J, Chen H, Zhao M, Peng S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b71e198e060471ab3a6f1dd26df725b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
por: Liu W, et al.
Publicado: (2019) -
SIMULTANEOUS DETERMINATION OF PHENYLEPHRINE HYDROCHLORIDE AND TROPICAMIDE IN OPHTHALMIC DOSAGE FORM WITH THREE RAPID DERIVATIVE SPECTROPHOTOMETRIC METHODS
por: SARDANA,SWATI, et al.
Publicado: (2010) -
Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA
por: Wu J, et al.
Publicado: (2018) -
Association Study of Genetic Variants in Calcium Signaling-Related Genes With Cardiovascular Diseases
por: Sen Li, et al.
Publicado: (2021) -
Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo
por: Zhao S, et al.
Publicado: (2019)